pantethine has been researched along with Cataract in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, JI | 1 |
| Avetisov, SÉ; Muranov, KO; Ostrovskiĭ, MA; Polianskiĭ, NB; Polunin, GS; Sheremet, NL | 1 |
| Horváth, Z; Vécsei, L | 1 |
| Clark, JI; Hiraoka, T | 1 |
| Clark, JI; Hiraoka, T; LI, XY; Thurston, GM | 1 |
| Clark, JI; Livesey, JC; Steele, JE | 1 |
| Clark, JI; David, LL; Hiraoka, T; Matsushima, H | 1 |
| Cole, L; Congdon, NT; Duncan, DT; Fisher, DT; Hazelwood, DT; McNaughton, C; Pham, T; Rieger, KT; Sanchez, AT; Urist, JT; Vitale, ST; West, ST | 1 |
| Harding, JJ | 1 |
3 review(s) available for pantethine and Cataract
| Article | Year |
|---|---|
Current medical aspects of pantethine.
Topics: Acetylcholine; Animals; Antioxidants; Atherosclerosis; Blood Platelets; Cataract; Central Nervous System; Coenzyme A; Cystine; Cystinosis; Dietary Carbohydrates; Fatty Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Peroxidation; Oxidation-Reduction; Pantetheine; Pantothenic Acid; Pyruvates | 2009 |
Pantethine. Monograph.
Topics: Animals; Antioxidants; Apolipoproteins B; Cataract; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Lipid Peroxides; Pantetheine | 2010 |
Can drugs or micronutrients prevent cataract?
Topics: Aldehyde Reductase; Aspirin; Cataract; Clinical Trials as Topic; Drug Design; Estrogens; Glutathione; Humans; Pantetheine | 2001 |
7 other study(ies) available for pantethine and Cataract
| Article | Year |
|---|---|
Self-assembly of protein aggregates in ageing disorders: the lens and cataract model.
Topics: Aging; alpha-Crystallin B Chain; Animals; Cataract; Lens, Crystalline; Models, Biological; Molecular Chaperones; Pantetheine; Protein Conformation; Protein Unfolding | 2013 |
[Deceleration of cataract development in rats under the action of N-acetylcarnosine and D-pantethine mixture].
Topics: Animals; Carnosine; Cataract; Chromatography, Gel; Drug Combinations; Eye Proteins; Injections, Intraperitoneal; Lens, Crystalline; Male; Ophthalmic Solutions; Pantetheine; Protective Agents; Protein Aggregates; Radiation Injuries, Experimental; Rats; Rats, Wistar; Solubility; Ultraviolet Rays | 2014 |
Inhibition of lens opacification during the early stages of cataract formation.
Topics: Animals; Animals, Newborn; Cataract; Disease Models, Animal; Female; Injections, Subcutaneous; Lens, Crystalline; Male; Pantetheine; Rats; Rats, Sprague-Dawley; Sodium Selenite; Time Factors | 1995 |
Effect of selected anti-cataract agents on opacification in the selenite cataract model.
Topics: Animals; Antioxidants; Cataract; Chelating Agents; Disulfides; Pantetheine; Phosphates; Rats; Rats, Sprague-Dawley; Sodium Selenite; Temperature; Tissue Extracts | 1996 |
Delay or inhibition of rat lens opacification using pantethine and WR-77913.
Topics: Amifostine; Animals; Cataract; Female; Galactose; Lens, Crystalline; Male; Pantetheine; Protein Denaturation; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; Sodium Selenite; Streptozocin | 1996 |
Loss of cytoskeletal proteins and lens cell opacification in the selenite cataract model.
Topics: Actins; Animals; Blotting, Western; Cataract; Crystallins; Cytoskeletal Proteins; Disease Progression; Lens Cortex, Crystalline; Lens Nucleus, Crystalline; Pantetheine; Rats; Rats, Sprague-Dawley; Sodium Selenite; Spectrin; Tubulin; Vimentin | 1997 |
The effect of pantethine and ultraviolet-B radiation on the development of lenticular opacity in the emory mouse.
Topics: Animals; Cataract; Cysteamine; Disease Models, Animal; Disease Progression; Female; Lens, Crystalline; Male; Mice; Mice, Inbred Strains; Pantetheine; Ultraviolet Rays | 2000 |